An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction

References

• Sung H, Ferlay J, Siegel RL. et al. Global cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca a Cancer J Clinicians. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhang H, Song X, Yang Q. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semi Cancer Biol. 2020;60:14–27. doi:10.1016/j.semcancer.2019.08.012
   PubMed Web of Science ®Google Scholar
• Bryan S, Witzel I, Borgmann K, Oliveira-Ferrer L. Molecular mechanisms associated with brain metastases in HER2-positive and triple negative breast cancers. Cancers. 2021;13(16). doi:10.3390/cancers13164137
   Web of Science ®Google Scholar
• Yu Z, Song M, Chouchane L, Ma X. Functional genomic analysis of breast cancer metastasis: implications for diagnosis and therapy. Cancers. 2021;13(13). doi:10.3390/cancers13133276
   Web of Science ®Google Scholar
• Palanca-Ballester C, Rodriguez-Casanova A, Torres S, et al. Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies. Cancers. 2021;13(12). doi:10.3390/cancers13123016
   PubMed Web of Science ®Google Scholar
• Kong Z, Han Q, Zhu B, Wan L, Feng E. Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR-136-5p/YWHAZ axis. Thorac Cancer. 2023;14(19):1831–1842. doi:10.1111/1759-7714.14928
   PubMed Web of Science ®Google Scholar
• Yang M, Lu H, Liu J, Wu S, Kim P, Zhou X. lncRNAfunc: a knowledgebase of lncRNA function in human cancer. Nucleic Acids Res. 2022;50(D1):D1295–D1306. doi:10.1093/nar/gkab1035
   PubMed Web of Science ®Google Scholar
• Ao YQ, Gao J, Jiang JH, Wang HK, Wang S, Ding JY. Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village. Mol Ther. 2023;23:00502. doi:10.1016/j.ymthe.2023.09.015
   Google Scholar
• Liu Y, Zhang P, Wu Q, et al. Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63. Nat Commun. 2021;12(1):5232. doi:10.1038/s41467-021-25552-0
   PubMed Web of Science ®Google Scholar
• Deng L, Wang J, Song J, et al. Long noncoding RNA SNHG1 promotes breast cancer progression by regulating the miR-641/RRS1 axis. Sci Rep. 2024;14(1):3265. doi:10.1038/s41598-024-52953-0
   PubMed Web of Science ®Google Scholar
• Ge X, Lei S, Wang P, Wang W, Wang W. The metabolism-related lncRNA signature predicts the prognosis of breast cancer patients. Sci Rep. 2024;14(1):3500. doi:10.1038/s41598-024-53716-7
   PubMedGoogle Scholar
• Yang Q, Fu Y, Wang J, Yang H, Zhang X. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer. J Zhejiang Univ Sci B. 2023;24(12):1123–1140. doi:10.1631/jzus.B2300067
   PubMed Web of Science ®Google Scholar
• Kramer I, Hooning MJ, Mavaddat N, et al. Breast cancer polygenic risk score and contralateral breast cancer risk. Am J Hum Genet. 2020;107(5):837–848. doi:10.1016/j.ajhg.2020.09.001
   PubMed Web of Science ®Google Scholar
• Ma D, Chen C, Wu J, Wang H, Wu D. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer. Breast Cancer. 2019;26(1):74–83. doi:10.1007/s12282-018-0891-3
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu L, Zhao J, et al. Construction and verification of a hypoxia-related 4-lncRNA model for prediction of breast cancer. Int J Gene Med. 2021;14:4605–4617. doi:10.2147/IJGM.S322007
   PubMed Web of Science ®Google Scholar
• Raju GSR, Pavitra E, Bandaru SS, et al. HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer. Mol Cancer. 2023;22(1):65. doi:10.1186/s12943-023-01765-3
   PubMed Web of Science ®Google Scholar
• Khaliefa AK, Desouky EM, Hozayen WG, Shaaban SM, Hasona NA. miRNA-1246, HOTAIR, and IL-39 signature as potential diagnostic biomarkers in breast cancer. Noncoding RNA Res. 2023;8(2):205–210. doi:10.1016/j.ncrna.2023.02.002
   PubMed Web of Science ®Google Scholar
• Semeraro MD, Smith C, Kaiser M, et al. Physical activity, a modulator of aging through effects on telomere biology. Aging. 2020;12(13):13803–13823. doi:10.18632/aging.103504
   PubMedGoogle Scholar
• Li H, Wei C, Zhou R, et al. Mouse models in modeling aging and cancer. Exp Gerontology. 2019;120:88–94. doi:10.1016/j.exger.2019.03.002
   PubMed Web of Science ®Google Scholar
• Pinzone MR, Berretta M, Doerr HW, Nunnari G, Cacopardo B. The complexity of aging: cancer risk among elderly people and infectious risk among those with cancer. Anti Can Agent Med Chem. 2013;13(9):1444–1448. doi:10.2174/18715206113136660346
   PubMed Web of Science ®Google Scholar
• Chatsirisupachai K, Palmer D, Ferreira S, de Magalhães JP. A human tissue-specific transcriptomic analysis reveals a complex relationship between aging, cancer, and cellular senescence. Aging Cell. 2019;18(6):1–5. doi:10.1111/acel.13041
   Web of Science ®Google Scholar
• Tang YF, Wang YZ, Wen GB, Jiang JJ. Prognostic model of kidney renal clear cell carcinoma using aging-related long noncoding RNA signatures identifies THBS1-IT1 as a potential prognostic biomarker for multiple cancers. Aging. 2023;15(17):8630–8663. doi:10.18632/aging.204949
   PubMedGoogle Scholar
• Hanahan D. Hallmarks of Cancer: new Dimensions. Cancer Discov. 2022;12(1):31–46. doi:10.1158/2159-8290.CD-21-1059
   PubMed Web of Science ®Google Scholar
• Xu Q, Chen Y. An aging-related gene signature-based model for risk stratification and prognosis prediction in lung adenocarcinoma. Front Cell Develop Biol. 2021;9:1–14. doi:10.3389/fcell.2021.685379
   Web of Science ®Google Scholar
• Chen X, Wang L, Hong L, et al. Identification of aging-related genes associated with clinical and prognostic features of hepatocellular carcinoma. Front Genetics. 2021;12:1–16. doi:10.3389/fgene.2021.661988
   Google Scholar
• Zhang X, Zhang H, Li J, et al. 6-lncRNA assessment model for MONITORING AND Prognosis of HER2-positive breast cancer: based on transcriptome data. Pathol Oncol Res. 2021;27:609083. doi:10.3389/pore.2021.609083
   PubMed Web of Science ®Google Scholar
• Ping L, Zhang K, Ou X, Qiu X, Xiao X. A novel pyroptosis-associated long non-coding RNA signature predicts prognosis and tumor immune microenvironment of patients with breast cancer. Front Cell Develop Biol. 2021;9:727183. doi:10.3389/fcell.2021.727183
   PubMed Web of Science ®Google Scholar
• Luo D, Yao W, Wang Q, et al. The nomogram based on the 6-lncRNA model can promote the prognosis prediction of patients with breast invasive carcinoma. Sci Rep. 2021;11(1):1–17. doi:10.1038/s41598-021-00364-w
   PubMed Web of Science ®Google Scholar
• Zhang M, Ma J, Guo Q, Ding S, Wang Y, Pu H. CD8+ T cell-associated gene signature correlates with prognosis risk and immunotherapy response in patients with lung adenocarcinoma. Front Immunol. 2022;13:1–19. doi:10.3389/fimmu.2022.806877
   Web of Science ®Google Scholar
• Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nature Med. 2018;24(10):1550–1558. doi:10.1038/s41591-018-0136-1
   PubMed Web of Science ®Google Scholar
• Tabl AA, Alkhateeb A, ElMaraghy W, Rueda L, Ngom A. A machine learning approach for identifying gene biomarkers guiding the treatment of breast cancer. Front Genet. 2019;10:256. doi:10.3389/fgene.2019.00256
   PubMed Web of Science ®Google Scholar
• Haybittle JL, Blamey RW, Elston CW, et al. A prognostic index in primary breast cancer. Br J Cancer. 1982;45(3):361–366. doi:10.1038/bjc.1982.62
   PubMed Web of Science ®Google Scholar
• Zhou L, Rueda M, Alkhateeb A. Classification of breast cancer Nottingham prognostic index using high-dimensional embedding and residual neural network. Cancers. 2022;14(4):934. doi:10.3390/cancers14040934
   PubMed Web of Science ®Google Scholar
• Yan S, Wang W, Zhu B, Pan X, Wu X, Tao W. Construction of nomograms for predicting pathological complete response and tumor shrinkage size in breast cancer. Cancer Manag Res. 2020;12:8313–8323. doi:10.2147/CMAR.S270687
   PubMed Web of Science ®Google Scholar
• Jiawei W, Xiajun B, Tian S, Xuzheng G, Zhenwang Z. Comprehensive analysis of PLKs expression and prognosis in breast cancer. Cancer Genet. 2022;268–269:83–92. doi:10.1016/j.cancergen.2022.09.007
   PubMed Web of Science ®Google Scholar
• Peng Y, Mei W, Ma K, Zeng C. Circulating tumor DNA and Minimal Residual Disease (MRD) in solid tumors: current horizons and future perspectives. Front Oncol. 2021;11:763790. doi:10.3389/fonc.2021.763790
   PubMed Web of Science ®Google Scholar
• Carapeto PV, Aguayo-Mazzucato C. Effects of exercise on cellular and tissue aging. Aging. 2021;13(10):14522–14543. doi:10.18632/aging.203051
   PubMedGoogle Scholar
• Zhu J, Wang F, Shi L, et al. Accelerated aging in breast cancer survivors and its association with mortality and cancer recurrence. Breast Cancer Res Treat. 2020;180(2):449–459. doi:10.1007/s10549-020-05541-5
   PubMed Web of Science ®Google Scholar
• Molinaro AM, Hervey-Jumper S, Morshed RA, et al. Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol. 2020;6(4):495–503. doi:10.1001/jamaoncol.2019.6143
   PubMed Web of Science ®Google Scholar
• Gnanavel M, Murugesan A, Mani SK, Kandhavelu M, Yli-Harja O. Identifying the miRNA signature association with aging-related senescence in glioblastoma. Int J Mol Sci. 2021;22(2):1–14. doi:10.3390/ijms22020517
   Web of Science ®Google Scholar
• Luo H, Tao C, Long X, Huang K, Zhu X. A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma. Aging. 2021;13(12):16198–16218. doi:10.18632/aging.203146
   PubMedGoogle Scholar
• Yue T, Chen S, Zhu J, et al. The aging-related risk signature in colorectal cancer. Aging. 2021;13(5):7330–7349. doi:10.18632/aging.202589
   PubMedGoogle Scholar
• Xu Q, Chen S, Hu Y, Huang W. Landscape of immune microenvironment under immune cell infiltration pattern in breast cancer. Front Immunol. 2021;12:711433. doi:10.3389/fimmu.2021.711433
   PubMed Web of Science ®Google Scholar
• Yang J, Jiang Q, Liu L, et al. Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma. Aging. 2020;12(24):25778–25804. doi:10.18632/aging.104199
   PubMedGoogle Scholar
• Zhang Y, Yan Y, Ning N, Shen Z, Ye Y. A signature of 24 aging‑related gene pairs predict overall survival in gastric cancer. Biomed Eng Online. 2021;20(1):1–14. doi:10.1186/s12938-021-00871-x
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xiu B, Zhang L, et al. Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization. J Immunother Cancer. 2022;10(10):e004666. doi:10.1136/jitc-2022-004666
   PubMed Web of Science ®Google Scholar
• Liu J, Lao L, Chen J, et al. The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancer. Nat Cancer. 2021;2(4):457–473. doi:10.1038/s43018-021-00196-7
   PubMedGoogle Scholar
• Zhao Y, Yu Z, Ma R, et al. lncRNA-Xist/miR-101-3p/KLF6/C/EBPα axis promotes TAM polarization to regulate cancer cell proliferation and migration. Mol Ther Nucleic Acids. 2021;23:536–551. doi:10.1016/j.omtn.2020.12.005
   PubMedGoogle Scholar
• Huang Z, Yu P, Tang J. Characterization of triple-negative breast cancer MDA-MB-231 cell spheroid model. Onco Targets Ther. 2020;13:5395–5405. doi:10.2147/OTT.S249756
   PubMed Web of Science ®Google Scholar
• Wei Y, Li Y, Chen Y, et al. ALDH1: a potential therapeutic target for cancer stem cells in solid tumors. Front Oncol. 2022;12:1026278. doi:10.3389/fonc.2022.1026278
   PubMedGoogle Scholar
• Wu H, Huang D, Zhou H, et al. Metformin: a promising drug for human cancers. Oncol Lett. 2022;24(1):204. doi:10.3892/ol.2022.13325
   PubMed Web of Science ®Google Scholar
• Li H, Shi W, Shen T, et al. Network pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer. Medicine. 2023;102(41):e35384. doi:10.1097/MD.0000000000035384
   PubMed Web of Science ®Google Scholar